Table 2.
Subgroups | Number of studies | Number of participants | Meta-analyses, mean difference (95% CI) | Statistical heterogeneity | Test for differences between subgroups | ||
---|---|---|---|---|---|---|---|
P value | I 2 value | P value | I 2 value | ||||
Change from baseline to 6 months | |||||||
Subgroups on treatment settings | |||||||
Specialist health care | 8 | 816 | −1.28 (−1.82 to −0.74) | <0.00001 | 76% | 0.02 | 68.7% |
Primary health care | 2 | 505 | −0.10 (−0.64 to 0.43) | 0.70 | 0% | ||
Schools | 3 | 213 | −0.90 (−1.66 to −0.13) | 0.02 | 65% | ||
Internet | 1 | 57 | −0.84 (−1.49 to −0.19) | 0.01 | NA | ||
Subgroups on treatment organization | |||||||
Group treatment | 8 | 827 | −1.20 (−1.69 to −0.70) | <0.00001 | 74% | 0.0002 | 88.4% |
Individual treatment | 5 | 698 | −0.39 (−0.75 to −0.03) | 0.03 | 0% | ||
Group and Individual treatment | 1 | 66 | −1.61 (−2.09 to −1.13) | <0.00001 | NA | ||
| |||||||
Change from baseline to 12 months | |||||||
Subgroups on treatment settings | |||||||
Specialist health care | 6 | 871 | −1.07 (−2.12 to −0.02) | 0.05 | 89% | 0.05 | 62.7% |
Primary health care | 6 | 1424 | −0.25 (−0.44 to −0.07) | 0.007 | 3% | ||
Schools | 6 | 886 | −0.66 (−1.40 to 0.08) | 0.08 | 81% | ||
Internet | 1 | 57 | −1.36 (−2.28 to −0.44) | 0.004 | NA | ||
Subgroups on treatment organization | |||||||
Group treatment | 13 | 1893 | −0.84 (−1.41 to −0.27) | 0.004 | 84% | 0.26 | 26.4% |
Individual treatment | 5 | 1254 | −0.32 (−0.57 to −0.06) | 0.02 | 32% | ||
Group and Individual treatment | 1 | 91 | −0.41 (−1.18 to 0.36) | 0.3 | NA | ||
| |||||||
Change from baseline to 24 months | |||||||
Subgroups on treatment settings | |||||||
Specialist health care | 5 | 546 | −0.74 (−1.66 to 0.19) | 0.12 | 75% | 0.41 | 0% |
Primary health care | 1 | 151 | −1.00 (−2.45 to 0.45) | 0.18 | NA | ||
Schools | 2 | 131 | −1.59 (−2.45 to −0.72) | 0.0003 | 0% | ||
Subgroups on treatment organization | |||||||
Group treatment | 7 | 737 | −1.02 (−1.84 to −0.19) | 0.02 | 70% | 0.62 | 0% |
Individual treatment | 0 | 0 | Not estimable | NA | NA | ||
Group and Individual treatment | 1 | 91 | −0.73 (−1.51 to 0.05) | 0.07 | NA |
NA = not applicable.